[1] O'HARA C M,BRENNER F W,MILLER J M.Classification,identification,and clinical significance of Proteus,Providencia,and Morganella[J].Clinical Microbiology Reviews,2000,13(4):534-546.
[2] ADEOLU M,ALNAJAR S,NAUSHAD S,et al.Genome-based phylogeny and taxonomy of the 'Enterobacteriales':Proposal for Enterobacterales ord.nov.divided into the families Enterobacteriaceae,Erwiniaceae fam.nov.,Pectobacteriaceae fam.nov.,Yersiniaceae fam.nov.,Hafniaceae fam.nov.,Morganellaceae fam.nov.,and Budviciaceae fam.nov[J].International Journal of Systematic and Evolutionary Microbiology,2016,66(12):5575-5599.
[3] WENNER J J,RETTGER L F.A systematic study of the proteus group of bacteria[J].Journal of Bacteriology,1919,4:331-353.
[4] ARMBRUSTER C E,MOBLEY H L T.Merging mythology and morphology:The multifaceted lifestyle of Proteus mirabilis[J].Nature Reviews Microbiology,2012,10(11):743-754.
[5] 王岩,尹珺伊,侯美如,等.鹅源奇异变形杆菌的分离鉴定及药敏试验[J].中国家禽,2017,39(23):56-59. WANG Y,YIN J Y,HOU M R,et al.Isolation,identification and drug sensitivity test of Proteus mirabilis[J].China Poultry,2017,39(23):56-59.(in Chinese)
[6] 徐睿,李颜桃.鸡源致病性奇异变形杆菌的分离鉴定与遗传进化分析[J].中国畜牧兽医,2018,45(9):2550-2558. XU R,LI Y T.Isolation,identification and genetic evolution analysis of chicken pathogenic Proteus mirabilis[J].China Animal Husbandry & Veterinary Medicine,2018,45(9):2550-2558.(in Chinese)
[7] 赵振鹏,杨振,林伟东,等.猪源奇异变形杆菌的分离鉴定及集群运动分析[J].中国畜牧兽医,2014,41(10):219-224. ZHAO Z P,YANG Z,LIN W D,et al.Isolation,identification and swarming motility analysis of Proteus mirabilis from pig[J].China Animal Husbandry & Veterinary Medicine,2014,41(10):219-224.(in Chinese)
[8] 王丹阳,王旭荣,张康,等.牛病毒性腹泻病毒、大肠杆菌和奇异变形杆菌混合感染致犊牛腹泻的研究[J].中国畜牧兽医,2018,45(1):189-195. WANG D Y,WANG X R,ZHANG K,et al.Study on diarrhea caused by mixed infection of bovine viral diarrhea virus, Escherichia coli and Proteus mirabilis[J].China Animal Husbandry & Veterinary Medicine,2018,45(1):189-195.(in Chinese)
[9] 曾邦权,段博芳,郑欢莉,等.牛奇异变形杆菌的分离鉴定及16S rRNA基因系统发育分析[J].中国畜牧兽医文摘,2018,34(4):71-73. ZENG B Q,DUAN B F,ZHENG H L,et al.Isolation,identification and phylogenetic analysis of 16S rRNA gene of Proteus mirabilis[J].Chinese Journal of Animal Husbandry and Veterinary Medicine,2018,34(4):71-73.(in Chinese)
[10] 王建科,程悦宁,易立,等.水貂奇异变形杆菌的分离鉴定及16S rRNA基因序列分析[J].中国畜牧兽医,2015,42(4):852-858. WANG J K,CHENG Y N,YI L,et al.Isolation,identification of mink Proteus mirabilis and sequence analysis of 16S rRNA gene[J].China Animal Husbandry & Veterinary Medicine,2015,42(4):852-858.(in Chinese)
[11] 陈曦,王远微,王永,等.山羊腹泻粪便中奇异变形杆菌的分离鉴定及系统发育分析[J].中国畜牧兽医,2014,41(8):215-218. CHEN X,WANG Y W,WANG Y,et al.Isolation,identification and phylogenetic analysis of Proteus mirabilis from goats with diarrhea[J].China Animal Husbandry & Veterinary Medicine,2014,41(8):215-218.(in Chinese)
[12] RÓZALSKI A,KWIL I,TORZEWSKA A,et al.Proteus bacilli:Features and virulence factors[J].Postepy Higieny I Medycyny Doswiadczalnej,2007,61:204-219.
[13] CHEN C Y,CHEN Y H,LU P L,et al.Proteus mirabilis urinary tract infection and bacteremia:Risk factors,clinical presentation,and outcomes[J].Journal of Microbiology Immunology and Infection,2012,45(3):228-236.
[14] ENDIMIANI A,LUZZARO F,BRIGANTE G.Proteus mirabilis bloodstream infections:Risk factors and treatment outcome related to the expression of extended-spectrum-lactamases[J].Antimicrobial Agents and Chemotherapy,2005,49(7):2598-2605.
[15] AHN J Y,ANN H W,JEON Y,et al.The impact of production of extended-spectrum β-lactamases on the 28-day mortality rate of patients with Proteus mirabilis bacteremia in Korea[J].BMC Infectious Diseases,2017,17:327.
[16] KANAYAMA A,KOBAYASHI I,SHIBUYA K.Distribution and antimicrobial susceptibility profile of extended-spectrum β-lactamase-producing Proteus mirabilis strains recently isolated in Japan[J]. International Journal of Antimicrobial Agents,2015,45(2):113-118.
[17] ENGDA T,MOGES F,GELAW A,et al.Prevalence and antimicrobial susceptibility patterns of extended spectrum beta-lactamase producing Entrobacteriaceae in the University of Gondar Referral Hospital environments,Northwest Ethiopia[J].BMC Research Notes,2018,22,11(1):335.
[18] SHENOY S M,MOHIT M,SINHA R.Antibiotic sensitivity pattern of clinical isolates of Proteus species with special reference to ESBL and Amp C production[J].Indian Journal of Pure and Applied Physics,2013,3(3):293-294.
[19] STURENBURG E,MACK D.Extended-spectrum β-lactamases:Implications for the clinical microbiology laboratory,therapy,and infection control[J]. International Journal of Infectious Diseases,2003,47(4):273-295.
[20] MODI D,PATEL D,PATEL S,et al.Comparison of various methods for the detection of extended spectrum beta lactamase in Klebsiella pneumoniae isolated from neonatal Intensive Care Unit,Ahmedabad[J].National Journal of Medical Research,2012,2:348-353.
[21] SINGHAI S,MATHUR T,KHAN S,et al.Evaluation of methods for AmpC beta-lactamase in Gram negative clinical isolates from tertiary care hospitals[J].Indian Journal of Microbiology,2005,23(2):120-124.
[22] BONNET R,SAMPAIO J L,LABIA R,et al.A novel CTX-M β-lactamase (CTX-M-8) in cefotaxime-resistant Enterobacteriaceae isolated in Brazil[J].Antimicrobial Agents & Chemotherapy,2000,44(7):1936-1942.
[23] DE CHAMPS C,MONNE C,BONNET R,et al.New TEM variant (TEM-92) produced by Proteus mirabilis and Providencia stuartii isolates[J].Antimicrob Agents Chemother,2001,45(4):1278-1280.
[24] FLUIT A C,JONES M E,SCHMITZ F J,et al.Antimicrobial resistance among urinary tract infection (UTI) isolates in Europe:Results from the SENTRY Antimicrobial Surveillance Program 1997[J].Antonie Leeuwenhoek,2000,77(2):147-152.
[25] WANG J T,CHEN P C,CHANG S C,et al.Antimicrobial susceptibilities of Proteus mirabilis:A longitudinal nationwide study from the Taiwan surveillance of antimicrobial resistance (TSAR) program[J].BMC Infectious Diseases,2014,14:486.
[26] PQTERSON D L,BONOMO R A.Extended-spectrum beta-lactamases:A clinical update[J].Clinical Microbiology Reviews,2005,18:657-686.
[27] YANG Q,ZHANG H,WANG Y,et al.Antimicrobial susceptibilities of aerobic and facultative Gram-negative bacilli isolated from Chinese patients with urinary tract infections between 2010 and 2014[J].BMC Infectious Diseases,2017,17(1):192. |